This literature is presented as a service to Inhalation’s readers. Content is provided by the companies listed. No product endorsement or preference is intended.
LITERATURE REVIEW
This literature, from Inhalation's advertisers, is presented as a service to readers.
Content is provided by the companies listed. No product endorsement or preference
is intended.
Astech
"Overview of Astech Project's
comprehensive portfolio of next
generation automated drug deliv-
ery testing solutions for the major
pharmacopoeia tests encountered in
respiratory."
https://astechprojects.co.uk/wp-
content/uploads/2021/06/ASTECH-
DRUG-DELIVERY.pdf
Catalent
Discover insights into intranasal
vaccine formulation development
and the opportunities for intranasal
approaches, including the importance
of device selection in determining
product performance. Learn more:
https://www.catalent.com/
expert-content/inhalation/
unraveling-complexities-in-
nasal-vaccine-development-
manufacturing-and-device-
selection/
Copley Scientific
In this article, we look at how in
vitro nasal drug product testing is
being refined for greater repeatability
and to maximize its value as a low-
cost tool for product development,
including an assessment of the role of
automation in improving the sensitiv-
ity of in vitro testing.
bit.ly/in-vitro-nasal-drug-product-
testing
Intertek
White Paper: IVBE Particle Charac-
terisation of Generic Mometasone
Furoate using MDRS & Laser Diffrac-
tion. Orthogonal methodologies to
assess API particles supporting IVBE
approaches for generic nasal suspen-
sion products.
https://bit.ly/IVBE-Particle-
Characterization
Lonza
Particle engineering, a core strength
of Lonza, is critical in achieving the
particle size distribution required for
effective drug delivery using dry pow-
der inhaler (DPI) devices.
https://pharma.lonza.com/
technologies-products/particle-
engineering-inhalation-applications
Proveris
®
Laboratories
Proveris Laboratories will partner with
you to use its 25+ years' experience in
the ONIDP space to help you complete
your development projects on time
and budget. Testing includes traditional
US FDA required analytical methods as
well as new contract service offerings
to support alternative approaches to
in vitro bioequivalence outlined in the
recent US FDA Guidances.
https://www.proveris.com/why-
proveris/
Inhalation August 2022 33
